Koninklijke DSM NV
AEX:DSM
Koninklijke DSM NV
EPS (Diluted)
Koninklijke DSM NV
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Koninklijke DSM NV
AEX:DSM
|
EPS (Diluted)
€9
|
CAGR 3-Years
32%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Corbion NV
AEX:CRBN
|
EPS (Diluted)
€1
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Akzo Nobel NV
AEX:AKZA
|
EPS (Diluted)
€3
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-1%
|
See Also
What is Koninklijke DSM NV's EPS (Diluted)?
EPS (Diluted)
9.8
EUR
Based on the financial report for Dec 31, 2022, Koninklijke DSM NV's EPS (Diluted) amounts to 9.8 EUR.
What is Koninklijke DSM NV's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
0%
Over the last year, the EPS (Diluted) growth was 1%. The average annual EPS (Diluted) growth rates for Koninklijke DSM NV have been 32% over the past three years .